Literature DB >> 24559280

Venous thromboembolism in the setting of pediatric traumatic brain injury.

Dominic A Harris1, Sandi Lam.   

Abstract

OBJECT: The risk of venous thromboembolism (VTE) in children with traumatic brain injury (TBI) has not been well characterized given its rarity in the pediatric population. Investigation of risk factors for VTE in this group requires the use of a large sample size. Using nationally representative hospital discharge data for 2009, the authors of this study characterize the incidence and risk factors for VTE in children hospitalized for TBI.
METHODS: The authors conducted a cross-sectional study using data from the Healthcare Cost and Utilization Project Kids' Inpatient Database to examine VTE in TBI-associated hospitalizations for patients 20 years of age or younger during the year 2009.
RESULTS: There were 58,529 children with TBI-related admissions, including 267 with VTE diagnoses. Venous thromboembolisms occurred in 4.6 per 1000 TBI-associated hospitalizations compared with 1.2 per 1000 pediatric hospitalizations overall. By adjusted logistic regression, patients significantly more likely to be diagnosed with VTE had the following: older age of 15-20 years (adjusted odds ratio [aOR] 3.7, 95% CI 1.8-8.0), venous catheterization (aOR 3.0, 95% CI 2.0-4.6), mechanical ventilation (aOR 1.9, 95% CI 1.2-2.9), tracheostomy (aOR 2.3, 95% CI 1.3-4.0), nonaccidental trauma (aOR 2.8, 95% CI 1.1-6.9), increased length of stay (aOR 1.02, 95% CI 1.01-1.03), orthopedic surgery (aOR 2.4, 95% CI 1.8-3.4), and cranial surgery (aOR 1.8, 95% CI 1.1-2.8).
CONCLUSIONS: Using the Kids' Inpatient Database, the authors found that risk factors for VTE in the setting of TBI in the pediatric population include older age, venous catheterization, nonaccidental trauma, increased length of hospital stay, orthopedic surgery, and cranial surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24559280     DOI: 10.3171/2014.1.PEDS13479

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  8 in total

Review 1.  Hospital-associated venous thromboembolism in pediatrics: a systematic review and meta-analysis of risk factors and risk-assessment models.

Authors:  Arash Mahajerin; Brian R Branchford; Ernest K Amankwah; Leslie Raffini; Elizabeth Chalmers; C Heleen van Ommen; Neil A Goldenberg
Journal:  Haematologica       Date:  2015-05-22       Impact factor: 9.941

2.  Is there a "July effect" in pediatric neurosurgery?

Authors:  Yimo Lin; Rory R Mayer; Terence Verla; Jeffrey S Raskin; Sandi Lam
Journal:  Childs Nerv Syst       Date:  2017-05-13       Impact factor: 1.475

3.  Incidence of venous thromboembolism in hospitalized pediatric neurosurgical patients: a retrospective 25-year institutional experience.

Authors:  Mason A Brown; Daniel H Fulkerson
Journal:  Childs Nerv Syst       Date:  2019-11-05       Impact factor: 1.475

Review 4.  Neuroprotective measures in children with traumatic brain injury.

Authors:  Shruti Agrawal; Ricardo Garcia Branco
Journal:  World J Crit Care Med       Date:  2016-02-04

5.  Multicenter Review of Current Practices Associated With Venous Thromboembolism Prophylaxis in Pediatric Patients After Trauma.

Authors:  Amee M Bigelow; Katherine T Flynn-O'Brien; Pippa M Simpson; Mahua Dasgupta; Sheila J Hanson
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

Review 6.  Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism.

Authors:  Arash Mahajerin; Stacy E Croteau
Journal:  Front Pediatr       Date:  2017-04-10       Impact factor: 3.418

Review 7.  Venous Thromboembolism in Critical Illness and Trauma: Pediatric Perspectives.

Authors:  Ranjit S Chima; Sheila J Hanson
Journal:  Front Pediatr       Date:  2017-03-13       Impact factor: 3.418

8.  Venous thromboembolism following inpatient pediatric surgery: Analysis of 153,220 patients.

Authors:  Brandon A Sherrod; Samuel G McClugage; Vincent E Mortellaro; Inmaculada B Aban; Brandon G Rocque
Journal:  J Pediatr Surg       Date:  2018-10-10       Impact factor: 2.545

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.